Key Companies Covered in the Global Breast Cancer Therapy Market Research Report by Kenneth Research are Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Pfizer Inc., PerkinElmer Inc., and Zimmer Biomet among and other key market players.
New York, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Kenneth Research has published a detailed market report on ‘Global Breast Cancer Therapy Market’ for the forecast period, i.e. 2022 – 2031, which includes the following factors:
Market growth over the forecast period
Detailed regional synopsis
Growth drivers and challenges
Key market players and their detailed profiling
Global Breast Cancer Therapy Market Size:
The global breast cancer therapy market generated the revenue figure of approximately USD 26 billion in the year 2021 and is anticipated to grow at a CAGR of ~10% over the forecast period, i.e., 2022 – 2031. The growth of the market can primarily be attributed to the growing incidences of breast cancer. Further, significantly rising consumption of junk or fried food among women across the world is resulting into upsurge of breast cancer worldwide. Hence, this is expected to be an important factor to fuel the market growth. A recent study indicates significant relationship between excessive consumption of fried foods among women and the odds of breast cancer. Breast cancer in women who frequently consumed fried foods were almost 5 times higher than among their counterparts.
Get Sample Copy of This Report @ https://www.kennethresearch.com/sample-request-10070786
Global Breast Cancer Therapy Market: Key Takeaways
The North America region gained the largest portion of the revenue in 2021
Targeted therapy segment to dominate the revenue graph
Oral sub-segment remains prominent in the route of administration segment
Rising Prevalence of Breast Cancer across the Globe to Boost Market Growth
Rising consumption of alcohol among the global women population, increasing cases of obesity, and increasing chances of getting exposed to radiation are responsible for the growth of the global breast cancer therapy market over the forecast period. As per the data by The World Bank, as of 2018, alcohol consumption per capita among global female population accounted to 2.6 liters of pure alcohol. Drinking alcohol, having family history of breast cancer, being obese, having postmenopausal hormone therapy, and other reasons increase chance of breast cancer largely.
In addition to this, development & launch of new screening programs, and the initiatives taken by governments around the world to spread awareness about the treatment options, and organizing free camps are anticipated to be major factors to boost the growth of the global breast cancer therapy market. Moreover, growing cases and deaths related to breast cancer have been increasing in the historical years. According to the World Health Organization, in 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. As of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer in the past 5 years, making it the world’s most prevalent cancer. Hence, this is expected to fuel the growth of the global breast cancer therapy market.
Browse to access In-depth research report on Global Breast Cancer Therapy Market with detailed charts and figures: https://www.kennethresearch.com/report-details/breast-cancer-therapy-market/10070786
Global Breast Cancer Therapy Market: Regional Overview
The global breast cancer therapy market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa region.
High Prevalence of Breast Cancer Drove Market Growth in the North America Region
The market in the North America region held the largest market share in the year 2021 as a result of growing prevalence of breast cancer. It was noted that, in the United States, after lung cancer, breast cancer is the second-leading cause of cancer death in women. It is also the leading cause of cancer related deaths among women ages 35 to 54. Furthermore, increasing healthcare expenditure over the region, and developed healthcare infrastructure are also anticipated to be significant factors to propel the growth of breast cancer therapy market in the region. As per The World Bank, healthcare expenditure, considering the total percentage of the GDP in the region, increased from 16.23% in 2018 to 16.32% in 2019.
Get a Sample PDF of Global Breast Cancer Therapy Market @ https://www.kennethresearch.com/sample-request-10070786
Constant Development in Healthcare Infrastructure to Favor Market Growth in the Asia Pacific Region
On the other hand, market in the Asia Pacific region is estimated to witness rapid growth by growing at a higher CAGR over the forecast period. The market growth can be majorly attributed to constant development in healthcare infrastructure, along with the government’s support services and initiatives to create awareness regarding cancer treatment among the mass. Moreover, the increasing cases of breast cancer in the region are anticipated to fuel the market growth majorly in this region. As per the Organization for Economic Co-operation and Development (OECD), nearly 839000 women were diagnosed with breast cancer in the year 2018 in the Asia Pacific region.
The study further incorporates Y-O-Y growth, demand & supply and forecast future opportunity in:
North America (U.S., Canada)
Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe)
Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific)
Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).
Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://www.kennethresearch.com/sample-request-10070786
Global Breast Cancer Therapy Market, Segmentation by Therapy
The targeted therapy segment is anticipated to hold largest market size in value and is estimated to grow at a notable CAGR over the forecast period. Targeted therapies are drugs or elements that stop the spread of cancer. The growth of the segment can be associated with the versatile nature of targeted therapy to pool with other therapies in order to show effective results against the cancer disease, and growing total drug expenditure for cancer treatment. Moreover, the research and development in clinical studies for targeted therapy is anticipated to create major opportunities for the growth of the segment in the coming years. A National Library of Medicine study showed that the total drug expenditure on anticancer therapy worldwide was approximately USD 1,011,133.65 as of 2020.
Global Breast Cancer Therapy Market, Segmentation by Route of Administration
The oral segment is estimated to hold a substantial market share during the forecast period. The growth of the segment can be attributed to the existence of a huge patient pool demanding targeted therapy using pills to treat breast cancer. Moreover, rising healthcare expenditure per capita on healthcare is also estimated to propel the growth of the breast cancer therapy market. According to the data by The World Bank, as of 2019, current health expenditure per capita among the global population was USD 1,121.97.
Global Breast Cancer Therapy Market, Segmentation by Cancer Type
Ductal Carcinoma In situ (DCIS)
Invasive Ductal Carcinoma (IDC)
Invasive Lobular Carcinoma (ILC)
Few of the well-known market leaders in the global breast cancer therapy market that are profiled by Kenneth Research are Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Pfizer Inc., PerkinElmer Inc., and others.
For More Information or Query or Customization Before Buying, Visit @ https://www.kennethresearch.com/sample-request-10070786
Recent Developments in the Global Breast Cancer Therapy Market
In August 2022, group of researchers working at Northern Ireland's Queen's University got a funding from Breast Cancer Now. The development is expected to improve anti-cancer drugs for protein p53 which is found in over 90% of breast cancer-specific tumors.
In August 2022, AstraZeneca in collaboration with Daiichi Sankyo have received FDA nod for Enhertu. the drug which is directed to treat breast cancer patients exhibiting low HER2 protein in their tumors.
Browse More Related Reports:
Biologics Market Analysis by Product Type (Monoclonal Antibodies, Recombinant Proteins/Hormones, Vaccines, and Cell & Gene Therapy); and by Application (Cancer, Infectious Disease, Immunological Disorders, Haematological Disorders, Cardiovascular Disease, and Others)-Global Supply & Demand Analysis & Opportunity Outlook 2022-2031
Healthcare Cold Chain Logistics Market Analysis by Product Type (Biopharmaceuticals, Clinical Trial Materials, Vaccines, and Others); and by Services (Storage, Packaging, Transportation, and Others)-Global Supply & Demand Analysis & Opportunity Outlook 2022-2031
Intracranial Pressure (ICP) Monitoring Market Analysis by Application (Traumatic Brain Injury, and Subarachnoid Hemorrhage); by End Users (Hospitals, Clinics, and Trauma Centers); and by Technique (Invasive, and Non-Invasive Monitoring)-Global Supply & Demand Analysis & Opportunity Outlook 2022-2031
Cardiac Implants Market Analysis by Application (Congestive Heart Failure, Myocardial Ischemia, Arrhythmias, and Acute Myocardial Infraction); by End-Users (Specialty Clinics, Hospitals, Ambulatory Surgical Centers, and Others); and by Device Type (Heart Value, Peacemakers, Coronary Stents, Ventricular Assist Devices, and Others)-Global Supply & Demand Analysis & Opportunity Outlook 2022-2031
Injectable Drug Delivery Devices Market Analysis by Product Type (Conventional, and Self-Injection Devices); by End Users (Hospital, Homecare, Clinics, and Others); and by Application (Curative Pattern, and Immunization)-Global Supply & Demand Analysis & Opportunity Outlook 2022-2031
About Kenneth Research
Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out-of-box thinking helps our clients to take wise decision so as to avoid future uncertainties.
Contact for more Info:
U.S. Phone: +1 313 462 0609